U.S. Medical Equipment Stock News

Gain Therapeutics’ Parkinson’s candidate GT-02287 showed durable clinical stability and biomarker improvements in extended Phase 1b data.

Walt Disney (DIS) remains a widely followed media and entertainment stock, with recent returns showing mixed momentum across different time frames as investors weigh its sprawling business, from streaming to theme parks. See our latest analysis for Walt Disney. At a share price of US$103.28, Walt Disney’s recent share price returns show only modest short term movement, while the one year total shareholder return is still down and the three year total shareholder return is positive, suggesting...

Vertiv Holdings Co (NYSE:VRT) has been selected by EcoDataCenter for an AI focused data center project in Sweden. The deal expands Vertiv's role in supplying integrated infrastructure for high performance computing in Northern Europe. This AI centric contract highlights Vertiv's growing international reach as competition from large infrastructure and technology peers intensifies. For investors watching Vertiv, the Sweden agreement adds a fresh data point to a stock that has already posted...

Dutch Bros Coffee has already opened its first Chicagoland shop in Melrose Park, Illinois, as part of its broader Midwest expansion, while also confirming participation in William Blair’s 46th Annual Growth Stock Conference in Chicago with a June 2, 2026 fireside chat webcast for investors. Together, the Chicago-area store launch and high-profile conference appearance highlight Dutch Bros’ effort to deepen its presence in a key new market while increasing engagement with institutional...

If you are wondering whether TechnipFMC at around US$71.41 is still offering value or starting to look stretched, the next sections will break down what the current price may be implying. The stock has pulled back recently, with the share price down 3.3% over the past week and 4.5% over the past month, while still sitting on a 50.9% gain year to date and a 137.0% gain over the past year. These moves have come as TechnipFMC continues to draw attention as an energy services stock, with...

RTX (RTX) is back in focus after a series of defense wins, including fresh DARPA funding for composable rocket motors, new Javelin launcher deliveries to the U.S. Army, and progress on secure military communications systems. See our latest analysis for RTX. RTX’s recent defense contract wins and technology milestones come as the stock trades at US$178.97, with short term share price momentum soft after a 90 day share price return that declined 8.68%. However, long term total shareholder...

Amprius Technologies (AMPX) is in focus after announcing a collaboration with drone operator Matternet that puts Amprius’ high energy silicon anode cells into Matternet’s M2 aircraft and future delivery platforms. See our latest analysis for Amprius Technologies. The stock has been volatile, with a 1 day share price return of 11.23% and a 7 day share price return of 15.18%. This is set against a 30 day share price return that is down 13.70% and a 90 day share price return of 61.21%. The year...

Apogee Therapeutics recently announced it would host a conference call and webcast on May 27, 2026, to present Part B 16-week data from its Phase 2 APEX trial of zumilokibart in moderate-to-severe atopic dermatitis. This planned disclosure marks another step in Apogee’s staged data-release approach for the APEX program, underscoring how clinical evidence is being sequenced to inform the therapy’s development pathway. We’ll now examine how the upcoming Phase 2 APEX data discussion for...

Enviri stock triggered review Enviri (NVRI) stock has drawn fresh attention after strong 1 year and past 3 months total returns, prompting investors to reassess the company’s environmental services business, segment mix, and current valuation profile. See our latest analysis for Enviri. With the share price at $19.80 and a 90 day share price return of 10.92% alongside a 1 year total shareholder return of 145.35%, recent momentum has added to what has already been a strong rebound story for...

Galaxy Digital (GLXY) has been drawing attention after recent share price moves, with the stock last closing at US$29.62. For context, the company reports annual revenue of US$58,713.02 and a net loss of US$67.08. See our latest analysis for Galaxy Digital. The recent 1 month share price return of 13.90% and 90 day gain of 29.74% sit on top of a 1 year total shareholder return of 36.25% and a very large 3 year total shareholder return of about 7x, suggesting momentum has been building rather...

JD.com (NasdaqGS:JD) continues to draw attention after recent share price moves, with the stock down 7.4% over the past week and up 8.9% in the past 3 months. See our latest analysis for JD.com. Recent moves fit a mixed picture, with the stock down over the past week but still showing a positive 3 month share price return. However, the 1 year total shareholder return remains weak, suggesting momentum is tentative rather than firmly established. If JD.com's recent swings have you reassessing...

In May 2026, Calix, Inc. launched secure, private AI agents and agentic workflows across its AI-native Calix One platform, powered by Google Cloud, while also expanding its Wi‑Fi 7 hardware portfolio to support residential, business, and multi-dwelling unit deployments. This combination of large-scale AI workflow orchestration, processing over a petabyte of data daily, and Wi‑Fi 7 appliances tightly integrated with Calix One strengthens Calix’s position as a full-stack provider for broadband...

HCA Healthcare expanded its partnership with the American Heart Association during Stroke Awareness Month to deepen its work in stroke prevention and treatment. The company highlighted its focus on rapid stroke treatment times and broader community outreach as part of this initiative. The development underscores HCA Healthcare's efforts to improve stroke care quality across its network of facilities. For investors tracking NYSE:HCA, this move comes with the stock at a share price of $392.42...

Check Point Software Technologies released its 2026 Cloud Security Report highlighting a 51-point gap between AI adoption and security readiness. The report points to broad structural vulnerabilities in cloud security that are not fully addressed by recent AI product launches. Findings focus on how quickly organizations are deploying AI workloads in the cloud compared with their ability to apply consistent, preventive controls. For investors watching NasdaqGS:CHKP, the timing of this report...

Oklo (NYSE:OKLO) has been selected by the U.S. Department of Energy for advanced negotiations under the Surplus Plutonium Utilization Program. The company is positioned to convert surplus plutonium into advanced reactor fuel in partnership with newcleo. This development relates to long running U.S. efforts to manage surplus nuclear materials while supporting advanced reactor technologies. Oklo focuses on compact advanced nuclear reactors aimed at supplying power for customers that want long...

Itron, Inc. recently expanded its collaboration with Hunter Water in New South Wales and completed a smart water management rollout for Thane Municipal Corporation in India, supplying digital meters and its Temetra cloud-based meter data management platform to modernize water networks. These projects highlight growing real-world adoption of Itron’s Temetra software and digital water metering in both developed and emerging markets, reinforcing the company’s position in utility...

Without a clear single news event driving the move, CoreCivic (CXW) has still been on investors’ radar recently as the stock’s performance and fundamentals invite closer inspection. See our latest analysis for CoreCivic. At a share price of $21.19, CoreCivic has seen a 23.41% 90 day share price return and an 11.41% year to date share price return, while its 3 year total shareholder return of 152.56% contrasts with a 5.49% decline over the past year. This suggests that longer term momentum has...

Snowflake (NYSE:SNOW) has secured a government wide "OneGov" agreement with the U.S. General Services Administration. The deal is designed to accelerate adoption of Snowflake's AI and cloud data products across federal agencies. The agreement establishes a common framework for U.S. government entities to access Snowflake's platform. For investors watching NYSE:SNOW, this OneGov agreement plugs the company directly into the federal IT buying channel, an area where AI, data sharing and...

Intuitive Machines (NasdaqGM:LUNR) was not selected for key Artemis Moon Base surface mobility contracts. NASA awarded major lunar vehicle and drone work to competitors including Astrolab, Lunar Outpost, Blue Origin, and Firefly Aerospace. The awards relate to infrastructure and transport systems for future Artemis lunar surface operations. For a company positioned as a specialist in lunar services and technology, Intuitive Machines missing out on these Artemis contracts puts the focus...

Dropbox (NasdaqGS:DBX) has appointed Ashraf Alkarmi as Co-CEO and Board Member, as part of a planned leadership transition. Andrew Houston will move into the Executive Chairman role. At that point, Alkarmi is expected to become sole CEO. Michael Torres has been hired as Chief Product Officer, bringing experience from senior roles at Alphabet and Amazon. For investors tracking Dropbox at a share price of $26.49, these executive changes arrive after mixed medium term returns. The stock is up...

RLX Technology Q1 earnings spark fresh look at the stock RLX Technology (RLX) released first quarter 2026 results, reporting sales of CN¥1,585.82 million and net income of CN¥284.14 million, along with higher basic and diluted earnings per share from continuing operations. See our latest analysis for RLX Technology. Despite the stronger first quarter figures, RLX Technology’s share price has eased. The 1 month share price return is down 9.38% and the year to date share price return is down...

Nuvation Bio’s manufacturing milestone with Thermo Fisher Nuvation Bio (NUVB) has completed the process technology transfer and product introduction for its lead therapy IBTROZI (taletrectinib) to Thermo Fisher Scientific in the US, a step that directly affects future drug supply. This transition, submitted as a supplement to Nuvation Bio’s IBTROZI New Drug Application for advanced or metastatic ROS1-positive non small cell lung cancer, positions Thermo Fisher as the company’s US manufacturer...

Phillips 66 (PSX) has drawn fresh attention after its recent share performance, with the stock last closing at US$173.88 and showing mixed returns over the past week and month for investors tracking momentum. See our latest analysis for Phillips 66. Recent trading has cooled slightly, with the share price down 4.66% over the past week. However, it is still showing a 6.77% 1 month share price gain and a 33.17% year to date share price return. The 1 year total shareholder return of 57.30% and 3...

Centuri Holdings (CTRI) has drawn fresh attention after reporting Q1 2026 revenue up 31% year over year and gross profit up 76%, alongside $1.3b in bookings and a backlog reaching $6.5b. See our latest analysis for Centuri Holdings. At a share price of $31.32, Centuri’s recent 3.71% 1 day and 8.15% 7 day share price returns follow a period where the 30 day share price return fell 9.84%. The year to date share price return of 21.30% and 1 year total shareholder return of 58.02% show notable...